Amrutanjan Health Care
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Amrutanjan Health Care is navigating a strategic pivot to bolster its revenue growth amid challenges in its core Pain Management segment. Management's focus on expanding the Women’s Hygiene and personal care categories, particularly through the new sanitary napkin facility in Telangana, is expected to enhance production capacity and market share. This diversification is crucial as the Pain Management business faces headwinds from changing consumer preferences and inventory adjustments. Vista's financial outlook anticipates double-digit revenue and operating profit growth, supported by these strategic initiatives. However, the company must contend with rising input costs and regulatory scrutiny, which could pressure margins. The broader pharmaceutical B2C industry is experiencing growth, driven by product launches and market expansion, although margin pressures persist. Over the next 12-24 months, key opportunities include the successful monetization of new manufacturing assets and the expansion of the 'Plastry' and razor portfolios. Conversely, watchpoints include the volatility of raw material costs and the competitive landscape in the personal care market
Why We Like This Stock
- Expansion into the women's hygiene segment through a new manufacturing facility is expected to enhance market share
- Management's focus on digital transformation and e-commerce is likely to improve operational efficiency and reach
- The anticipated double-digit growth in revenue and operating profits reflects confidence in the company's strategic initiatives
Things To Watch Out For
- Rising input costs and regulatory scrutiny may pressure margins in the near term
- The core Pain Management segment faces structural challenges from shifting consumer preferences
- Increased competition in the personal care market necessitates sustained marketing investment to maintain market share
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 421 | 452 | 503 | 516 | 567 |
| Profit Before Tax (Cr.) | 62 | 69 | 87 | 83 | 93 |
| PBT Margin | 14.7% | 15.3% | 17.2% | 16.2% | 16.4% |
| Net Profit (Cr.) | 46 | 51 | 62 | 63 | 70 |
| Earnings Per Share | 16.0 | 17.8 | 21.4 | 21.6 | 24.1 |
Analyst Recommendations
No analyst recommendations available.
Company Overview
Show Company Profile
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene & Personal Care, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn corn caps; hand sanitizer under the NOGerms brand name; and enerlyte and electro, and fruit and rehydration juice drinks under the Fruitnik brand name. The company also offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints, as well as provides sanitary napkins for women. In addition, it operates a pain management center. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.